807
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Genome-wide analysis of DNA 5-hmC in peripheral blood of uremia by hMeDIP-chip

, , , , , , , , , , & show all
Pages 937-945 | Received 21 Dec 2013, Accepted 21 Feb 2014, Published online: 03 Apr 2014

References

  • Shalhoub V, Shatzen EM, Ward SC, et al. FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality. J Clin Invest. 2012;122(7):2543–2553
  • Haddy FJ, Meyer TW, Hostetter TH. Uremia. N Engl J Med. 2008;358(1):95 . doi: 10.1056/NEJMc073016
  • Girndt M. Clinical issues with uremia. Internist (Berl). 2012;53(7):817–822
  • Gernsheimer T, James AH, Stasi R. How I treat thrombocytopenia in pregnancy. Blood. 2013;121(1):38–47
  • Liakopoulos V, Georgianos PI, Eleftheriadis T, Sarafidis PA. Epigenetic mechanisms and kidney diseases. Curr Med Chem. 2011;18(9):1733–1739
  • Zawada AM, Rogacev KS, Heine GH. Clinical relevance of epigenetic dysregulation in chronic kidney disease-associated cardiovascular disease. Nephrol Dial Transplant. 2013;28(7):1663–1671
  • Stenvinkel P, Ekström TJ. Epigenetics and the uremic phenotype: a matter of balance. Contrib Nephrol. 2008;161:55–62
  • Zawada AM, Rogacev KS, Hummel B, et al. SuperTAG methylation-specific digital karyotyping reveals uremia-induced epigenetic dysregulation of atherosclerosis-related genes. Circ Cardiovasc Genet. 2012;5(6):611–620
  • Ingrosso D, Perna AF. Epigenetics in hyperhomocysteinemic states. A special focus on uremia. Biochim Biophys Acta. 2009;1790(9):892–899
  • Tahiliani M, Koh KP, Shen Y, et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science. 2009;324(5929):930–935
  • Huang Y, Pastor WA, Shen Y, Tahiliani M, Liu DR, Rao A. The behavior of 5-hydroxymethylcytosine in bisulfite sequencing. PLoS One. 2010;5(1):e8888. doi: 10.1371/journal.pone.0008888
  • Gao F, Xia Y, Wang J, et al. Integrated detection of both 5-mC and 5-hmC by high-throughput tag sequencing technology highlights methylation reprogramming of bivalent genes during cellular differentiation. Epigenetics. 2013;8(4) [Epub ahead of print]
  • Ito S, D'Alessio AC, Taranova OV, Hong K, Sowers LC, Zhang Y. Role of TET proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification. Nature. 2010;466(7310):1129–1133
  • Tsumagari K, Baribault C, Terragni J, et al. Early denovo DNA methylation and prolonged demethylation in the muscle lineage. Epigenetics. 2013;8(3):317–332
  • Yamaguchi S, Hong K, Liu R, et al. Dynamics of 5-methylcytosine and 5-hydroxymethylcytosine during germ cell reprogramming. Cell Res. 2013;23(3):329–339
  • Jin SG, Kadam S, Pfeifer GP. Examination of the specificity of DNA methylation profiling techniques towards 5-methylcytosine and 5-hydroxymethylcytosine. Nucleic Acids Res. 2010;38(11):e125. doi: 10.1093/nar/gkq223
  • Wu SC, Zhang Y. Active DNA demethylation: many roads lead to Rome. Nat Rev Mol Cell Biol. 2010;11(9):607–620
  • Williams K, Christensen J, Helin K. DNA methylation: TET proteins-guardians of CpG islands? EMBO Rep. 2011;13(1):28–35
  • Song CX, Yi C, He C. Mapping recently identified nucleotide variants in the genome and transcriptome. Nat Biotechnol. 2012;30(11):1107–1116
  • Stroud H, Feng S, Morey Kinney S, Pradhan S, Jacobsen SE. 5-Hydroxymethylcytosine is associated with enhancers and gene bodies in human embryonic stem cells. Genome Biol. 2011;12(6):R54. doi: 10.1186/gb-2011-12-6-r54
  • Xu Y, Wu F, Tan L, et al. Genome-wide regulation of 5hmC, 5mC, and gene expression by Tet1 hydroxylase in mouse embryonic stem cells. Mol Cell. 2011;42(4):451–464
  • Gao Y, Chen J, Li K, et al. Replacement of Oct4 by Tet1 during iPSC induction reveals an important role of DNA methylation and hydroxymethylation in reprogramming. Cell Stem Cell. 2013;12(4):453–469
  • Thomson JP, Lempiäinen H, Hackett JA, et al. Non-genotoxic carcinogen exposure induces defined changes in the 5-hydroxymethylome. Genome Biol. 2012;13(10):R93. doi: 10.1186/gb-2012-13-10-r93
  • Jackson SA, Sridharan R. The nexus of Tet1 and the pluripotency network. Cell Stem Cell. 2013;12(4):387–388
  • Honda T, Ogata S, Mineo E, et al. A novel strategy for hemolytic uremic syndrome: successful treatment with thrombomodulin α. Pediatrics. 2013;131(3):e928–e933
  • Zawada AM, Rogacev KS, Hummel B, et al. SuperTAG methylation-specific digital karyotyping reveals uremia-induced epigenetic dysregulation of atherosclerosis-related genes. Circ Cardiovasc Genet. 2012;5(6):611–620
  • Zoja C, Locatelli M, Pagani C, et al. Lack of the lectin-like domain of thrombomodulin worsens Shiga toxin-associated hemolytic uremic syndrome in mice. J Immunol. 2012;189(7):3661–3668
  • Schaefer F, Yoon SA, Nouri P, et al. Growth hormone-mediated janus associated kinase-signal transducers and activators of transcription signaling in the growth hormone-resistant potassium-deficient rat. J Am Soc Nephrol. 2004;15(9):2299–2306
  • Rabkin R, Sun DF, Chen Y, Tan J, Schaefer F. Growth hormone resistance in uremia, a role for impaired JAK/STAT signaling. Pediatr Nephrol. 2005;20(3):313–318
  • Shimizu H, Yisireyili M, Nishijima F, Niwa T. Stat3 contributes to indoxyl sulfate-induced inflammatory and fibrotic gene expression and cellular senescence. Am J Nephrol. 2012;36(2):184–189

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.